메뉴 건너뛰기




Volumn 208, Issue 1, 2010, Pages 197-202

Apolipoprotein E genotype predicts cardiovascular endpoints in dialysis patients with type 2 diabetes mellitus

Author keywords

apoE genotype; Atorvastatin treatment; Cardiovascular risk; Haemodialysis; Type 2 diabetes

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; APOLIPOPROTEIN E; ATORVASTATIN; C REACTIVE PROTEIN; LIPOPROTEIN; PLACEBO;

EID: 73449085118     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.06.036     Document Type: Article
Times cited : (16)

References (22)
  • 2
    • 0024299370 scopus 로고
    • Apolipoprotein E: cholesterol transport protein with expanding role in cell biology
    • Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240 (1988) 622-630
    • (1988) Science , vol.240 , pp. 622-630
    • Mahley, R.W.1
  • 3
    • 0023860891 scopus 로고
    • Apolipoprotein E polymorphism and atherosclerosis
    • Davignon J., Gregg R.E., and Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8 (1988) 1-21
    • (1988) Arteriosclerosis , vol.8 , pp. 1-21
    • Davignon, J.1    Gregg, R.E.2    Sing, C.F.3
  • 4
    • 0037318641 scopus 로고    scopus 로고
    • The molecular genetics of cardiovascular disease: clinical implications
    • Stephens J.W., and Humphries S.E. The molecular genetics of cardiovascular disease: clinical implications. J Intern Med 253 (2003) 120-127
    • (2003) J Intern Med , vol.253 , pp. 120-127
    • Stephens, J.W.1    Humphries, S.E.2
  • 5
    • 0027194791 scopus 로고
    • Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
    • Corder E.H., Saunders A.M., Strittmatter W.J., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
    • (1993) Science , vol.261 , pp. 921-923
    • Corder, E.H.1    Saunders, A.M.2    Strittmatter, W.J.3
  • 6
    • 0032587143 scopus 로고    scopus 로고
    • Competition of Ab amyloid peptide and apolipoprotein E for receptor-mediated endocytosis
    • Winkler K., Scharnagl H., Tisljar U., et al. Competition of Ab amyloid peptide and apolipoprotein E for receptor-mediated endocytosis. J Lipid Res 40 (1999) 447-455
    • (1999) J Lipid Res , vol.40 , pp. 447-455
    • Winkler, K.1    Scharnagl, H.2    Tisljar, U.3
  • 7
    • 3142706539 scopus 로고    scopus 로고
    • Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease
    • Song Y., Stampfer M.J., and Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 141 (2004) 137-147
    • (2004) Ann Intern Med , vol.141 , pp. 137-147
    • Song, Y.1    Stampfer, M.J.2    Liu, S.3
  • 8
    • 0023393613 scopus 로고
    • Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype
    • Kesaniemi Y.A., Ehnholm C., and Miettinen T.A. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 80 (1987) 578-581
    • (1987) J Clin Invest , vol.80 , pp. 578-581
    • Kesaniemi, Y.A.1    Ehnholm, C.2    Miettinen, T.A.3
  • 9
    • 0032948510 scopus 로고    scopus 로고
    • Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes
    • Mamotte C.D., Sturm M., Foo J.I., van Bockxmeer F.M., and Taylor R.R. Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes. Am J Physiol 276 (1999) E553-E557
    • (1999) Am J Physiol , vol.276
    • Mamotte, C.D.1    Sturm, M.2    Foo, J.I.3    van Bockxmeer, F.M.4    Taylor, R.R.5
  • 10
    • 34548736492 scopus 로고    scopus 로고
    • Association of apolipoprotein E genotypes with lipid levels and coronary risk
    • Bennet A.M., Di Angelantonio E., Ye Z., et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 298 (2007) 1300-1311
    • (2007) JAMA , vol.298 , pp. 1300-1311
    • Bennet, A.M.1    Di Angelantonio, E.2    Ye, Z.3
  • 11
    • 0042821576 scopus 로고    scopus 로고
    • Impact of dyslipidemia in end-stage renal disease
    • Prichard S.S. Impact of dyslipidemia in end-stage renal disease. J Am Soc Nephrol 14 (2003) S315-S320
    • (2003) J Am Soc Nephrol , vol.14
    • Prichard, S.S.1
  • 12
    • 0032973549 scopus 로고    scopus 로고
    • Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Die Deutsche Diabetes Dialyse Studie Investigators
    • Wanner C., Krane V., Ruf G., Marz W., and Ritz E. Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Die Deutsche Diabetes Dialyse Studie Investigators. Kidney Int Suppl 71 (1999) S222-S226
    • (1999) Kidney Int Suppl , vol.71
    • Wanner, C.1    Krane, V.2    Ruf, G.3    Marz, W.4    Ritz, E.5
  • 13
    • 22344458137 scopus 로고    scopus 로고
    • Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
    • Wanner C., Krane V., Marz W., et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353 (2005) 238-248
    • (2005) N Engl J Med , vol.353 , pp. 238-248
    • Wanner, C.1    Krane, V.2    Marz, W.3
  • 14
    • 63849163945 scopus 로고    scopus 로고
    • Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
    • Fellstrom B.C., Jardine A.G., Schmieder R.E., et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360 (2009) 1395-1407
    • (2009) N Engl J Med , vol.360 , pp. 1395-1407
    • Fellstrom, B.C.1    Jardine, A.G.2    Schmieder, R.E.3
  • 15
    • 4644272251 scopus 로고    scopus 로고
    • Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics
    • Wanner C., Krane V., and Marz W. Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics. Kidney Blood Press Res 27 (2004) 259-266
    • (2004) Kidney Blood Press Res , vol.27 , pp. 259-266
    • Wanner, C.1    Krane, V.2    Marz, W.3
  • 16
    • 0024284028 scopus 로고
    • A simple salting out procedure for extracting DNA from human nucleated cells
    • Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
    • (1988) Nucleic Acids Res , vol.16 , pp. 1215
    • Miller, S.A.1    Dykes, D.D.2    Polesky, H.F.3
  • 17
    • 0030870822 scopus 로고    scopus 로고
    • Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes
    • Zivelin A., Rosenberg N., Peretz H., et al. Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin Chem 43 (1997) 1657-1659
    • (1997) Clin Chem , vol.43 , pp. 1657-1659
    • Zivelin, A.1    Rosenberg, N.2    Peretz, H.3
  • 19
    • 30744476783 scopus 로고    scopus 로고
    • Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis
    • Ikewaki K., Schaefer J.R., Frischmann M.E., et al. Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis. Arterioscler Thromb Vasc Biol 25 (2005) 2615-2622
    • (2005) Arterioscler Thromb Vasc Biol , vol.25 , pp. 2615-2622
    • Ikewaki, K.1    Schaefer, J.R.2    Frischmann, M.E.3
  • 20
    • 50849099502 scopus 로고    scopus 로고
    • Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients
    • Winkler K., Wanner C., Drechsler C., et al. Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients. Eur Heart J (2008)
    • (2008) Eur Heart J
    • Winkler, K.1    Wanner, C.2    Drechsler, C.3
  • 21
    • 56549092147 scopus 로고    scopus 로고
    • Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis
    • Krane V., Winkler K., Drechsler C., et al. Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis. Kidney Int (2008)
    • (2008) Kidney Int
    • Krane, V.1    Winkler, K.2    Drechsler, C.3
  • 22
    • 9644267020 scopus 로고    scopus 로고
    • The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study)
    • Marz W., Scharnagl H., Hoffmann M.M., Boehm B.O., and Winkelmann B.R. The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study). Eur Heart J 25 (2004) 2109-2119
    • (2004) Eur Heart J , vol.25 , pp. 2109-2119
    • Marz, W.1    Scharnagl, H.2    Hoffmann, M.M.3    Boehm, B.O.4    Winkelmann, B.R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.